Close Menu

Selventa

Selventa Raises $5M

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Life science data analysis firm Selventa has raised $5 million in an equity round, it disclosed in a document filed with the US Securities and Exchange Commission this week.

Selventa said this week that it has partnered with Linguamatics to add natural language processing-based text-mining capability to its knowledge-extraction and discovery platform.

Selventa CEO David de Graaf has been selected to serve on the scientific advisory board of the Massachusetts Institute of Technology's Center for Cancer Systems Biology.

The Swiss Institute of Bioinformatics has tapped Selventa's CEO David de Graaf and Alexey Nesvizhskii, an assistant professor at the University of Michigan, Ann Arbor, to serve on its scientific advisory board.

Movers & Shakers: Aug 19, 2011

Premium

The Swiss Institute of Bioinformatics has appointed David de Graaf and Alexey Nesvizhskii to serve on its scientific advisory board.

Luis Serrano, James Collins, Mathukumalli Vidyasagar, Joel Saltz

Pfizer and Selventa plan to create a publicly available version of Selventa's Biological Expression Language and associated BEL Framework that will enable groups to capture, store, combine, and use scientific knowledge to inform decision-making for drug targets.

John Tagliamonte

Pages

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.